129 related articles for article (PubMed ID: 20400929)
1. Denosumab findings in metastatic breast cancer.
Stopeck A
Clin Adv Hematol Oncol; 2010 Mar; 8(3):159-60. PubMed ID: 20400929
[No Abstract] [Full Text] [Related]
2. Denosumab an option for patients with bone metastasis from breast cancer.
Barton MK
CA Cancer J Clin; 2011; 61(3):135-6. PubMed ID: 21532096
[No Abstract] [Full Text] [Related]
3. Role of denosumab in breast cancer.
Bartsch R; Steger GG
Expert Opin Biol Ther; 2009 Sep; 9(9):1225-33. PubMed ID: 19653867
[TBL] [Abstract][Full Text] [Related]
4. Bone targeted therapy in breast cancer: present and future.
Huober J; Thürlimann B
Crit Rev Oncol Hematol; 2010 Apr; 74 Suppl 1():S7-10. PubMed ID: 20427030
[No Abstract] [Full Text] [Related]
5. Denosumab for treatment of breast cancer bone metastases and beyond.
Nangia JR; Ma JD; Nguyen CM; Mendes MA; Trivedi MV
Expert Opin Biol Ther; 2012 Apr; 12(4):491-501. PubMed ID: 22348344
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer bone metastases: denosumab or zoledronic acid?
van der Pluijm G
Nat Rev Endocrinol; 2011 Mar; 7(3):134-5. PubMed ID: 21343953
[No Abstract] [Full Text] [Related]
7. Extended efficacy and safety of denosumab in breast cancer patients with bone metastases not receiving prior bisphosphonate therapy.
Lipton A; Steger GG; Figueroa J; Alvarado C; Solal-Celigny P; Body JJ; de Boer R; Berardi R; Gascon P; Tonkin KS; Coleman RE; Paterson AH; Gao GM; Kinsey AC; Peterson MC; Jun S
Clin Cancer Res; 2008 Oct; 14(20):6690-6. PubMed ID: 18927312
[TBL] [Abstract][Full Text] [Related]
8. Denosumab: benefits of RANK ligand inhibition in cancer patients.
Lipton A; Jacobs I
Curr Opin Support Palliat Care; 2011 Sep; 5(3):258-64. PubMed ID: 21826000
[TBL] [Abstract][Full Text] [Related]
9. Denosumab for bone metastases.
Med Lett Drugs Ther; 2011 Jan; 53(1356):8. PubMed ID: 21252843
[No Abstract] [Full Text] [Related]
10. Denosumab for bone metastases from breast cancer: a new therapy option?
Aapro MS
J Clin Oncol; 2011 May; 29(14):e419-20; author reply e421-4. PubMed ID: 21464408
[No Abstract] [Full Text] [Related]
11. Denosumab: second chapter in controlling bone metastases or a new book?
Fornier MN
J Clin Oncol; 2010 Dec; 28(35):5127-31. PubMed ID: 21060038
[No Abstract] [Full Text] [Related]
12. Preventing metastases to bone: denosumab or bisphosphonates?
Nanes MS
J Bone Miner Res; 2010 Mar; 25(3):437-9. PubMed ID: 20200989
[No Abstract] [Full Text] [Related]
13. Bone-modifying agents in the treatment of advanced cancer.
Ritchie KL
S D Med; 2011 May; 64(5):167-8. PubMed ID: 21661342
[No Abstract] [Full Text] [Related]
14. A step in the journey of denosumab from bone-targeted therapy to seed- and soil-targeted therapy.
Vignot S; Khayat D
J Clin Oncol; 2009 Apr; 27(10):1534-6. PubMed ID: 19237628
[No Abstract] [Full Text] [Related]
15. [Involvement of RANKL/RANK pathway in bone metastasis in breast cancer].
Yoneda T
Clin Calcium; 2011 Aug; 21(8):1159-66. PubMed ID: 21814020
[TBL] [Abstract][Full Text] [Related]
16. Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates.
Fizazi K; Lipton A; Mariette X; Body JJ; Rahim Y; Gralow JR; Gao G; Wu L; Sohn W; Jun S
J Clin Oncol; 2009 Apr; 27(10):1564-71. PubMed ID: 19237632
[TBL] [Abstract][Full Text] [Related]
17. Denosumab for prevention of skeletal-related events in patients with bone metastases from solid tumors: incremental benefit, debatable value.
West H
J Clin Oncol; 2011 Mar; 29(9):1095-8. PubMed ID: 21343550
[No Abstract] [Full Text] [Related]
18. Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma.
Henry DH; Costa L; Goldwasser F; Hirsh V; Hungria V; Prausova J; Scagliotti GV; Sleeboom H; Spencer A; Vadhan-Raj S; von Moos R; Willenbacher W; Woll PJ; Wang J; Jiang Q; Jun S; Dansey R; Yeh H
J Clin Oncol; 2011 Mar; 29(9):1125-32. PubMed ID: 21343556
[TBL] [Abstract][Full Text] [Related]
19. Denosumab in breast cancer.
Lipton A
Curr Oncol Rep; 2011 Feb; 13(1):1-4. PubMed ID: 21053109
[TBL] [Abstract][Full Text] [Related]
20. Denosumab.
Pageau SC
MAbs; 2009; 1(3):210-5. PubMed ID: 20065634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
